LONDON (ShareCast) - (Sharecast News) - Seed Innovations reported on Wednesday that its portfolio company, Little Green Pharma (LGP), has completed the acquisition of Health House, a medicinal cannabis distribution business in Australia.
The AIM-traded firm said the acquisition would strengthen LGP's vertical integration, and aligned with its long-term expansion strategy amid the restructuring of the Australian medicinal cannabis industry.

Health House, a long-standing distribution partner of LGP, generates about $7.5m in annual revenue and has reached cash flow breakeven.

The deal involved a net cash payment of around $0.38m, with LGP also assuming an estimated $0.35m in net liabilities, excluding existing payables owed to LGP.

Seed highlighted the value of the acquisition, noting that Health House's parent company, Melodiol Global Health had previously listed the business for sale at $10.9m last September.

Seed holds 7,324,796 ordinary shares in LGP, representing approximately 2.4% of the company's issued share capital.

"LGP's acquisition of Health House strengthens its position in the rapidly growing Australian medicinal cannabis market by enhancing its distribution capabilities and reinforcing its vertical integration strategy," said Seed's director of investment research, Alfredo Pascual.

"This move comes amid ongoing industry consolidation and allows LGP to secure a key distribution partner at an attractive valuation, demonstrating its ability to execute disciplined, value-accretive growth.

"We are confident that this acquisition will create long-term value for both LGP and SEED shareholders."

At 0935 GMT, shares in Seed Innovations were down 8.57% at 1.6p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE